Douglas J. Warner - 19 Feb 2024 Form 4 Insider Report for eFFECTOR Therapeutics, Inc.

Role
Chief Medical Officer
Signature
/s/ Michael Byrnes, Attorney-in-Fact for Douglas J. Warner
Issuer symbol
EFTR on OTC
Transactions as of
19 Feb 2024
Net transactions value
$0
Form type
4
Filing time
21 Feb 2024, 17:00:03 UTC
Previous filing
19 Jan 2023
Next filing
10 Sep 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EFTR Stock Option (Right to Buy) Award $0 +25,000 $0.000000 25,000 19 Feb 2024 Common Stock 25,000 $11.32 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/48th of the total number of shares subject to the options shall vest on each monthly anniversary of February 19, 2024 (the "Vesting Commencement Date"), subject to the Reporting Person's continuous service to the Issuer on each such vesting date, so that the options shall be fully vested on the fourth anniversary of the Vesting Commencement Date.